Purpose
to enhance clinical trial site capabilities for Quality Assurance/Quality Control systems in preparation of conducting phase 3 COVID-19 vaccine efficacy trials in LMIC
Grantee
Division
Global Health
Date
AUGUST 2020
Region served
AFRICA,
AMERICA,
ASIA
Committed amount
$1,363,868
Grant topic
Pneumonia & Pandemic Preparedness,
Vaccine Development
Duration (months)
6
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.